ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,117.20
0.58%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/06/202407:05Business WireIMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placeboNASDAQ:AZNAstraZeneca PLC
02/06/202407:00Business WireENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapyNASDAQ:AZNAstraZeneca PLC
02/06/202407:00GlobeNewswire Inc.CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
02/06/202407:00Business WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
02/06/202407:00GlobeNewswire Inc.Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)NASDAQ:NTLAIntellia Therapeutics Inc
02/06/202407:00GlobeNewswire Inc.William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
02/06/202407:00Business WireMassive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
02/06/202407:00Business WireENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
02/06/202407:00PR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
02/06/202406:20PR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/
02/06/202406:20PR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024/
02/06/202406:00Business WireJune Joy at Juicy Stakes Casino
02/06/202406:00PR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024/
02/06/202406:00PR Newswire (US)Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
02/06/202406:00PR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire du premier ministre pour le dimanche 2 juin 2024/
02/06/202405:50NEWSBTCBitcoin In ‘Euphoria Wave’ – How Long Until The Bull Run Ends?COIN:QNTUSDQuant
02/06/202405:41Alliance NewsAlliance NewsIsrael fights Hamas as mediators urge both to accept Gaza truce plan
02/06/202405:35Alliance NewsAlliance NewsOPEC+ anxious to maintain unity as some members head to Riyadh
02/06/202405:32Alliance NewsAlliance NewsDong Jun says Beijing ready to "forcefully" stop Taiwan independence
02/06/202405:29Alliance NewsAlliance NewsNvidia head, top chip CEOs to lay out AI plans at Taiwan expoTG:NVDNVIDIA Corp
02/06/202405:20Alliance NewsAlliance NewsPRESS: Sanofi proceeds with EUR20 billion consumer healthcare spin-off
02/06/202405:18PR Newswire (US)Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
02/06/202405:00PR Newswire (Canada)/R E P R I S E -- Avis aux médias - En pleine négociation, les intervenantes en petite enfance de la FIPEQ-CSQ participeront à l'activité de mobilisation de Ma place au travail/
02/06/202405:00PR Newswire (Canada)/R E P E A T -- Media Advisory: Infrastructure Announcement in Halifax/
02/06/202405:00PR Newswire (Canada)/R E P R I S E -- Avis aux médias : Annonce en matière d'infrastructure à Halifax/
02/06/202404:33CointelegraphNigeria seeks crypto clarity one year into Tinubu’s tenureCOIN:BTCUSDBitcoin
02/06/202404:15The Daily HodlBillionaire Chamath Palihapitiya Says It Makes Sense for Countries To Hold Bitcoin in Dual-Currency EnvironmentCOIN:FETUSDFetch
02/06/202404:00PR Newswire (Canada)AVIS DE FERMETURE DE RUES : aujourd'hui, dimanche 2 juin, à l'occasion du Tour de l'Île de Montréal
02/06/202403:49NEWSBTCEthereum On Edge: Can Ether Smash Through Resistance Or Stall After Rally?COIN:MATICUSDPolygon
02/06/202403:46CointelegraphEl Salvador's pro-Bitcoin President Nayib Bukele sworn in for second termCOIN:BTCUSDBitcoin

Su Consulta Reciente

LSE
SMDS
Smith (ds)
ASX
HE8
Helios Energy
EU
HYDUS
BNP Paribas Asset Manage...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados